IL6 and cancer: NK-LAAO treatment using a non-toxic condition (0.1 μg/ml for 18 h) (Fig. S8) led to approximately 1.3- and 1.2-fold increases in the migratory and invasive abilities, respectively, of cancer cells while these effects could be counteracted by IL-6 depletion (Figs. 5G and H).